The researchers found that developing hybrid immunity was no different if someone was vaccinated after contracting Covid-19 or after contracting the disease after vaccination. Both groups developed an equally potent immune response.
For the first time since the beginning of the pandemic in early 2020, a majority of Americans dying from Covid were at least partially vaccinated, according to the new analysis of federal and state data.
On May 25, Union Health Minister Dr. Mansukh Mandaviya shared photos with Bill Gates.
The DCGI in April also granted an emergency use authorisation (EUA) to Covaxin for the age group of 6-12 years.
At present, the gap between the second Covid jab and the precaution dose is nine months.
After the announcement, vaccine maker Serum Institute of India (SII) said the precaution dose of its Covishield vaccine will be priced at Rs 600 per shot for eligible individuals.
This document also indicates that the vaccines have caused many leukaemia cases in a significant geographic span.
The decision was based on a study of 24,000 adults that found the vaccine was 71% effective at preventing COVID-19 - although that was before the omicron variant emerged. Side effects were mild, including fever and fatigue.
For the study, the team collected blood from 42 participants and lymph node samples from 15 participants before each person received his or her first dose of the Pfizer-BioNTech Covid-19 vaccine and at weeks three, four, five, seven, 15 and 29 afterwards. Eight people provided all three kinds of samples, allowing the researchers to track the development of the antibody response over time within those individuals.
An intranasal vaccine as a booster dose if becomes a reality would be easier to administer in mass vaccination campaigns and has the potential to prevent transmission.
India's COVID-19 vaccination coverage has crossed 156 crore with more than 57 lakh vaccine doses administered on Saturday, the Union health ministry said.
Most vaccinated users received the Pfizer and Moderna vaccines. On average, the first vaccination dose was associated with a .71-day cycle increase in cycle length and the second dose with a .91-day increase. Therefore, users vaccinated over two cycles had an increase of less than one day in each of the vaccination cycles.
DCGI has approved molnupiravir for the treatment of adult patients with Covid-19 who have high risk of progression of the disease including hospitalisation or death.
Eight Omicron cases have so far been reported in Uttar Pradesh and of the patients, three have recovered and the others are in home isolation, the chief minister said.
The registration for all potential beneficiaries on the Co-WIN portal had begun from January 1, 2022. They can also avail walk-in registration at the vaccination centres from today.
In the context of the vaccination of the age group 15-18 years, the Union Health Secretary informed the States/UTs that only 'Covaxin' is to be administered in this population category.
As on Friday afternoon, more than 144.67 crore doses of COVID-19 vaccines had been administered across the country.
India Recap 2021: India's journey throughout the year was full of many ups and downs. Let's take a quick recap of events that made headlines in 2021.
Explaining factors that account for a vaccine's effectiveness against COVID-19, Swaminathan said that vaccine effectiveness varies a little bit between vaccines though the majority of all of the WHO Emergency Use.
"It's a hat-trick! It's now 3rd vaccine developed in India!", Health Minister Mandaviya said.
Top News
Latest News
